+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Perfluorocarbon-based Ultrasound Contrast Agents Market - Global Forecast 2026-2032- Product Image
Perfluorocarbon-based Ultrasound Contrast Agents Market - Global Forecast 2026-2032- Product Image
Sale

Perfluorocarbon-based Ultrasound Contrast Agents Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145740
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Perfluorocarbon-based Ultrasound Contrast Agents Market is projected to reach USD 593.93 Million in 2026. It is expected to continue growing at a CAGR of 12.02%, reaching USD 1.18 Billion by 2032.

Perfluorocarbon-Based Ultrasound Contrast Agents: Executive Overview

Perfluorocarbon-based ultrasound contrast agents are engineered microbubble formulations that enhance ultrasound backscatter and improve visualization of blood flow, perfusion, and selected tissue structures. Their clinical relevance is linked to the safety advantages of ultrasound, the need for more sensitive contrast-enhanced imaging, and expanding interest in targeted, quantitative, and molecular applications. Adoption remains shaped by regulatory requirements, product standardization, reimbursement, operator expertise, and the availability of alternative imaging modalities.

Imaging Priorities Are Shifting Toward Safer, More Quantitative Diagnosis

The landscape is moving from conventional anatomical ultrasound toward contrast-enhanced, functional, and image-guided assessment. Perfluorocarbon formulations support this transition through gas stability, acoustic responsiveness, and potential compatibility with specialized delivery or targeting approaches. Key changes include greater emphasis on organ perfusion, treatment monitoring, point-of-care workflows, and repeatable examinations, while developers and providers continue addressing formulation consistency, shelf stability, administration protocols, and post-market evidence requirements.

Artificial Intelligence Strengthens Detection, Quantification, and Workflow Integration

Artificial intelligence can increase the practical value of contrast-enhanced ultrasound by improving microbubble signal detection, reducing motion and clutter artifacts, segmenting lesions, and quantifying perfusion dynamics. Machine-learning tools may also support protocol selection, automated quality checks, and longitudinal comparison of examinations. However, reliable deployment requires representative training data, transparent validation, interoperability with ultrasound systems, cybersecurity controls, and clinical oversight. AI is therefore an enabling layer rather than a substitute for contrast-agent safety evaluation or radiologist and sonographer judgment.

Regional Insights: Regulation and Clinical Infrastructure Shape Adoption

North America is characterized by advanced imaging infrastructure, specialist expertise, and active clinical evaluation, with adoption influenced by regulatory evidence and reimbursement pathways. Europe combines mature hospital systems with stringent safety, quality, and privacy expectations across national markets. Asia-Pacific presents diverse conditions, ranging from sophisticated tertiary-care capacity in Australia, Japan, and South Korea to rapidly developing diagnostic infrastructure elsewhere. Latin America is shaped by uneven access, import dependence, and concentration of specialist services. The Middle East is supported by investment in advanced hospitals and diagnostic centers, while procurement, training, and access constraints remain important in parts of Africa. Across all regions, local approvals, supply reliability, and clinician education are central implementation factors.

Group Insights: Cooperation Blends Opportunity With Compliance Complexity

ASEAN markets offer varied healthcare capacity and benefit from regional collaboration, although regulatory harmonization and access differ by country. BRICS members represent diverse clinical systems, manufacturing capabilities, and public-health priorities, making local evidence and procurement strategy important. The European Union emphasizes coordinated regulatory and quality frameworks alongside national reimbursement decisions. G7 countries generally provide strong research ecosystems, sophisticated imaging services, and demanding evidence standards. GCC markets are supported by concentrated healthcare investment and cross-border procurement, while workforce development remains relevant. NATO members span multiple health systems, but shared attention to resilience, supply continuity, and advanced medical technology can influence procurement planning.

Country Insights: National Evidence, Capacity, and Policy Determine Practical Use

Australia and Canada combine established healthcare systems with geographically dispersed service delivery, making workflow efficiency and specialist access important. Brazil, Mexico, India, and Russia face varied regional access and procurement conditions, increasing the importance of affordability, training, and reliable distribution. China is supported by substantial medical-technology capability and a large clinical base, with domestic regulatory and procurement requirements shaping deployment. France, Germany, Italy, Spain, and the United Kingdom have strong imaging expertise, but adoption depends on country-specific evidence, reimbursement, and hospital processes. Japan and South Korea bring advanced ultrasound practice and technology infrastructure, while the United States remains highly influenced by regulatory clearance, clinical guidelines, reimbursement, and integration into specialist care pathways.

Action Priorities for Leaders: Build Evidence, Usability, and Implementation Readiness

Industry leaders should prioritize well-designed clinical studies that demonstrate incremental diagnostic or procedural value in clearly defined indications. Product development should focus on reproducible microbubble performance, simple administration, storage resilience, and compatibility with installed ultrasound platforms. Partnerships with hospitals and professional societies can strengthen training, protocol standardization, and real-world evidence. Commercial planning should account for regional regulatory differences, reimbursement engagement, procurement requirements, and service support. AI-enabled features should be introduced with validated performance metrics, human oversight, and robust data governance. Leaders should also maintain diversified supply chains and prepare clear pharmacovigilance and risk-management processes.

Research Methodology: Evidence-Led Assessment of Clinical and Adoption Drivers

This executive summary uses a structured assessment of the perfluorocarbon-based ultrasound contrast-agent domain, organized around technology characteristics, clinical use cases, regulatory considerations, healthcare infrastructure, and implementation barriers. Regional, group, and country perspectives are synthesized from the specified geographic scope and interpreted through established factors affecting diagnostic-technology adoption, including evidence requirements, reimbursement, workforce capability, procurement, and supply continuity. The analysis intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Findings should be interpreted alongside current regulatory decisions, clinical guidelines, and institution-level validation.

Conclusion: Clinical Utility Will Depend on Demonstrated Value and Reliable Delivery

Perfluorocarbon-based ultrasound contrast agents occupy an important position in the evolution of ultrasound toward more sensitive and quantitative imaging. Their progress will depend less on technical promise alone than on demonstrated patient benefit, consistent product performance, practical workflows, and sustainable reimbursement. Regional differences require tailored regulatory and implementation strategies, while AI can enhance interpretation when deployed with rigorous validation and clinical governance. Organizations that align evidence generation, usability, training, supply resilience, and responsible digital integration will be best positioned to support durable clinical adoption.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Technology Type
7.1. Introduction
7.2. Liquids
7.2.1. Decafluorobutane
7.2.2. Perfluorooctyl Bromide
7.3. Microbubbles
7.3.1. Lipid Coated
7.3.2. Polymer Coated
7.3.3. Protein Coated
7.4. Nanobubbles
7.4.1. Lipid Coated
7.4.2. Protein Coated
8. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Application
8.1. Introduction
8.2. Cardiology
8.2.1. Left Ventricular Function Analysis
8.2.2. Myocardial Perfusion Imaging
8.3. Oncology
8.3.1. Lesion Detection
8.3.2. Tumor Characterization
8.4. Radiology
8.4.1. Abdominal Imaging
8.4.2. Pediatric Imaging
8.4.3. Vascular Imaging
9. Perfluorocarbon-based Ultrasound Contrast Agents Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Outpatient Clinics
9.2.2. Specialty Clinics
9.3. Diagnostic Centers
9.3.1. Cardiac Care Centers
9.3.2. Imaging Centers
9.4. Hospitals
9.5. Research Institutes
9.5.1. Academic Institutions
9.5.2. Contract Research Organizations
10. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Perfluorocarbon-based Ultrasound Contrast Agents Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Acusphere, Inc.
14.2. Bracco Suisse SA
14.3. Cellectar Biosciences, Inc.
14.4. Daiichi Sankyo Company, Limited
14.5. GE Healthcare
14.6. Imax Diagnostics AG
14.7. Koninklijke Philips N.V.
14.8. Lantheus Medical Imaging, Inc.
14.9. Mallinckrodt plc
14.10. MediLumine
14.11. NanoScan Imaging LLC
14.12. POINT Biopharma Global Inc.
14.13. SINUS Medical Ultrasound Technologies GmbH
14.14. Spago Nanomedical AB
14.15. Targeson, Inc.
14.16. VisualSonics Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market, Years Considered for the Study
FIGURE 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market, Research Design
FIGURE 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market, Research Framework
FIGURE 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Market, Data Triangulation
FIGURE 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2025 vs 2032 (%)
FIGURE 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Segmentation & Coverage
TABLE 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 4. Global Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Decafluorobutane Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Decafluorobutane Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Decafluorobutane Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Perfluorooctyl Bromide Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Perfluorooctyl Bromide Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Perfluorooctyl Bromide Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Microbubbles Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Microbubbles Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Microbubbles Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Lipid Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Lipid Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Lipid Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Polymer Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Polymer Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Polymer Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Protein Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Protein Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Protein Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Nanobubbles Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Nanobubbles Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Nanobubbles Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Lipid Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Lipid Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Lipid Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Protein Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Protein Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Protein Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 35. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Left Ventricular Function Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Left Ventricular Function Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Left Ventricular Function Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Myocardial Perfusion Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Myocardial Perfusion Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Myocardial Perfusion Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lesion Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lesion Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lesion Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Tumor Characterization Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Tumor Characterization Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Tumor Characterization Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Radiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Radiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Radiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Abdominal Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Abdominal Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Abdominal Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Pediatric Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Pediatric Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Pediatric Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Vascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Vascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Vascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Outpatient Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Outpatient Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Outpatient Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Cardiac Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Cardiac Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Cardiac Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 110. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 112. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 113. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 114. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 115. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 117. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 118. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 119. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 121. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 122. North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 123. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 125. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 126. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 127. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 128. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 130. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 131. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 132. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 134. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 135. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 136. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 138. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 139. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 140. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 141. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 143. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 144. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 145. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 147. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 148. Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 149. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 151. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 152. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 153. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 154. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 156. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 157. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 158. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 160. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 161. Middle East Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 162. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 164. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 165. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 166. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 167. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 169. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 170. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 171. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 173. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 174. Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 175. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 178. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 179. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 180. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 181. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 183. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 184. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 185. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 187. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 188. ASEAN Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 189. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 191. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 192. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 193. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 194. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 196. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 197. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 198. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 200. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 201. GCC Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 202. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 204. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 205. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 206. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 207. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 209. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 210. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 211. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 213. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 214. European Union Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 215. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 217. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 218. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 219. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 220. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 222. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 223. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 224. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 226. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 227. BRICS Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 228. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 230. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 231. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 232. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 233. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 235. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 236. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 237. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 239. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 240. G7 Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 241. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 243. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 244. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 245. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 246. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 248. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 249. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 250. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 252. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 253. NATO Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 254. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 256. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 257. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 258. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 259. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 260. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 262. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 263. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 264. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 266. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 267. United States Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 268. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 269. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 270. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 271. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 272. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 273. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 275. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 276. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 277. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 279. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 280. Canada Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 281. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 282. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 283. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 284. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 285. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 286. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 288. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 289. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 290. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 292. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 293. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 294. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 295. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 296. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Liquids, 2017-2032 (USD Million)
TABLE 297. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Microbubbles, 2017-2032 (USD Million)
TABLE 298. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Nanobubbles, 2017-2032 (USD Million)
TABLE 299. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Brazil Perfluorocarbon-based Ultrasound Contrast Agen

Companies Mentioned

  • Acusphere, Inc.
  • Bracco Suisse SA
  • Cellectar Biosciences, Inc.
  • Daiichi Sankyo Company, Limited
  • GE Healthcare
  • Imax Diagnostics AG
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt plc
  • MediLumine
  • NanoScan Imaging LLC
  • POINT Biopharma Global Inc.
  • SINUS Medical Ultrasound Technologies GmbH
  • Spago Nanomedical AB
  • Targeson, Inc.
  • VisualSonics Inc.

Related Topics

Related Reports

2025 Global Forecast for Ultrasound Contrast Agents Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Ultrasound Contrast Agents Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Perfluorocarbon Market - Global Strategic Business Report - Product Image

Perfluorocarbon Market - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Endoscopic Ultrasound Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Endoscopic Ultrasound Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Perfluorocarbon Market in Canada - Product Image

Perfluorocarbon Market in Canada

  • Report
  • 173 Pages
  • Canada
From
Perfluorocarbons Market - Global Forecast 2026-2032 - Product Image

Perfluorocarbons Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.